2022 ESC Guidelines on cardio-oncology

26 Aug 2022

This is the first European Society of Cardiology (ESC) guideline on cardio-oncology. The aim of this guideline is to help all the healthcare professionals providing care to oncology patients before, during, and after their cancer treatments with respect to their cardiovascular health and wellness. This guideline provides guidance on the definitions, diagnosis, treatment, and prevention of cancer therapy-related CV toxicity, and the management of CV disease caused directly or indirectly by cancer. This area of medicine has limited trials and evidence to base decision making and, where evidence is limited, this guideline provides the consensus of expert opinion to guide healthcare professionals.

Guidelines and related materials are for use by individuals for personal or educational purposes. No commercial use is allowed. Re-use permission must be correctly obtained from the publisher.

ESC Guidelines are protected by copyright. As per opt out option under Article 4 §3 of EU Directive 2019/790, the ESC reserves all rights to license uses of ESC Guidelines to train or develop generative artificial intelligence (AI) models, large language models or other deep learning or machine learning models. Any use of ESC Guidelines in software tools, generative AI models, computational models, or algorithms in which ESC Guideline content is included, cited, or transformed in any way requires a formal license agreement.

Topic(s):

Coronary CT Angiography

Electrocardiography

Cardiac Computed Tomography: Valvular Heart Disease

Cardiology

Cardio-Oncology

Imaging

Cardiac Computed Tomography: Myocardial Disease

Cardiac Computed Tomography

Echocardiography

Clinical Skills

Cardiac Computed Tomography: Morphology, Dimensions, Volumes and Mass

Cardiac Computed Tomography: Pericardial Disease

Cardiac Computed Tomography: Coronary Calcium Score

Cardiac Computed Tomography: Systolic and Diastolic Function

Endorsed by cardiac societies

Armenian Cardiologists Association , Austrian Society of Cardiology , Association of Cardiologists of Bosnia & Herzegovina , British Cardiovascular Society , Bulgarian Society of Cardiology , Croatian Cardiac Society , Czech Society of Cardiology , Danish Society of Cardiology , Egyptian Society of Cardiology , Estonian Society of Cardiology , Finnish Cardiac Society , French Society of Cardiology , German Cardiac Society , Hellenic Society of Cardiology , Hungarian Society of Cardiology , Italian Federation of Cardiology , Association of Cardiologists of Kazakhstan , Kyrgyz Society of Cardiology , Latvian Society of Cardiology , Lithuanian Society of Cardiology , Luxembourg Society of Cardiology , Maltese Cardiac Society , Norwegian Society of Cardiology , Polish Cardiac Society , Portuguese Society of Cardiology , Cardiology Society of Serbia , Slovak Society of Cardiology , Spanish Society of Cardiology , Swiss Society of Cardiology , Turkish Society of Cardiology , Ukrainian Association of Cardiology

Main resources

: Full text and related materials

Full text

https://doi.org/10.1093/eurheartj/ehac244

Corrigendum

Published on 7 May 2023

Declarations of interest

Read the full text

: More insights during the new conference

Join experts next June in Florence, Italy, for the new inaugural meeting on Cardio-Oncology.

The programme highlights guidelines in practice and establishes a dedicated platform for this rapidly advancing specialty.

Gain actionable insights directly applicable to your clinical practice.

See more and register now

More resources

: Webinar Series

What do the ESC 2022 Guidelines mean for you and your patients?